EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Immunologic studies of a spontaneous syngeneic tumor host system part 1 the role of immune mechanisms in tumor transplants in the syngeneic host






International Archives of Allergy & Applied Immunology 35(1): 20-34

Immunologic studies of a spontaneous syngeneic tumor host system part 1 the role of immune mechanisms in tumor transplants in the syngeneic host



Accession: 026767554



Related references

Abdou, N.I.; McKenna, J.M., 1969: Immunologic studies of a spontaneous syngeneic tumor-host system. I. The role of immune mechanisms in tumor transplants in the syngeneic host. International Archives of Allergy and Applied Immunology 35(1): 20-34

Abdou, N.I.; McKenna, J.M., 1968: Immunologic studies of a spontaneous syngeneic tumor-host system. II. Specific immune tolerance and adoptive tolerance by thymic grafts. International Archives of Allergy and Applied Immunology 34(6): 589-596

Abdou N.I.; Mckenna J.M., 1968: Immunologic studies of a spontaneous syngeneic neopl tumor host system specific immune tolerance and adoptive tolerance by thymic grafts mouse. International Archives of Allergy & Applied Immunology 34(6): 589-596

Nowak, C.; Arnold, W., 1976: Studies on biological characterization of mammary tumors of the sprague dawley rat in the syngeneic tumor host system part 2 establishment of transplantable mammary tumor lines. Seven spontaneous and 33 DMBA[dimethylbenzanthracene]-induced mammary tumors (Huggins tumors) of different histological types were transplanted s.c. Four transplantation lines were established from these tumors.

Kanagawa, O., 1978: Studies on the host immune response in cancer part 1 effect of immuno potentiators on mouse foot pad reaction against syngeneic tumor cell. The immuno-modulating effect of 3 immunopotentiators (OK-432 [a streptococcal extract], PS-K [extract from Coriolus versicolor] and levamisole) was studied in MH-134 bearing C3H/He mice using a foot pad reaction. When tumor bearing mice were injec...

Nowak C.; Elbe B.; Arnold W.; Bender E., 1973: Investigations of the influence of pre treatment with cyclo phosphamide ribo aza uracil and mercaleukin on experimental metastases in a syngeneic tumor host system part 1 spontaneous mammary carcinoma of the mouse. Archiv fuer Geschwulstforschung 41(1): 1-11

Shinoda, H.; Yamazaki, M.; Mizuno, D., 1977: Protective effect of syngeneic antitumor serum on mammary tumor in a syngeneic host. The possibility of passive immunotherapy was examined using syngeneic antitumor serum, which could lyse tumor cells in co-operation with immune or activated macrophages. Intraperitoneal injection of syngeneic antiserum into mice soon after inocula...

Devlin, R.G.; Mccurdy, J.D.; Baronowsky, P.E., 1974: Mixed lymphocyte reactivity against normal cells by splenic lymphocytes from tumor bearing mice part 2 studies of auto immune like activity in completely syngeneic and semi syngeneic systems. Journal of Experimental Medicine 139(1): 230-237

Nowak, C.; Arnold, W.; Mehnert, W.H., 1976: Studies on biological characterization of mammary tumors of the sprague dawley rat in the syngeneic tumor host system part 1 spontaneous primary mammary tumors and tumors induced by oral and intra venous application of di methyl benz anthracene. Spontaneous and DMBA[dimethylbenzanthracene]-induced mammary tumors of a Sprague-Dawley inbred line are described. The incidence of spontaneous tumors was 14.3%, and of chemically induced tumors, 43.6%, of all animals tested. Five schedules of app...

Bear, H.D.; Susskind, B.M.; Close, K.A.; Barrett, S.K., 1988: Phenotype of syngeneic tumor-specific cytotoxic T-lymphocytes and requirements for their in vitro generation from tumor-bearing host and immune spleens. Cells required for the in vitro generation of syngeneic cytotoxic T-lymphocytes (CTL) against the P815 mastocytoma in the DBA/2 mouse strain were investigated. For both immune and tumor-bearing host spleen cells, CTL effector cells were eliminated...